
Addus HomeCare (ADUS) Stock Forecast & Price Target
Addus HomeCare (ADUS) Analyst Ratings
Bulls say
Addus HomeCare Corp has demonstrated strong organic revenue growth in its Personal Care segment, reporting increases of 12.3% year-over-year in 2023, 7.7% in 2024, and 7.4% year-to-date in 2025, reflecting robust demand for non-medical in-home care services. Additionally, the recent 2.6% Medicare Hospice rate increase, effective October 1, 2025, is expected to enhance revenue for the Hospice segment, which is anticipated to grow by 5% to 7% as it stabilizes. The potential for growth is further supported by expected M&A activity and operational improvements in the Hospice division, which could provide additional revenue opportunities in the near term.
Bears say
Addus HomeCare Corp is facing a negative outlook primarily due to significant same-store declines in 2025 year-to-date results, attributed to ongoing impacts from Medicaid redeterminations that have created administrative bottlenecks for patient onboarding and increased discharge rates. Approximately 97% of the company’s segment revenues are reliant on Medicaid, making it vulnerable to uncertainties surrounding future funding after the enactment of the One Big Beautiful Bill Act (OBBBA). Furthermore, despite maintaining a favorable long-term demand backdrop and steady fundamental execution, the company's equity valuation has lagged behind the broader post-acute sector, indicating a disconnect between market performance and its financial fundamentals.
This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.
Addus HomeCare (ADUS) Analyst Forecast & Price Prediction
Start investing in Addus HomeCare (ADUS)
Order type
Buy in
Order amount
Est. shares
0 shares